Escitalopram versus sertraline in the treatment of major depressive disorder: A randomized clinical trial

Current Medical Research and Opinion

Volumn 23, Issue 2, 2007, Pages 245-250

  Ventura, Daniel ^a   Armstrong, Edward P ^b   Skrepnek, Grant H ^b   Erder, M Haim ^a  

^a FOREST RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Clinical trial; Dose response relationship; Double blind; Escitalopram; Major depressive disorder; Sertraline

Indexed keywords

ESCITALOPRAM; PLACEBO; SERTRALINE;

ADULT; AGED; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EJACULATION DISORDER; FEMALE; HEADACHE; HUMAN; INSOMNIA; LIBIDO DISORDER; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MULTICENTER STUDY; NAUSEA; OPTIMAL DRUG DOSE; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; SCORING SYSTEM; SOMNOLENCE; TREATMENT OUTCOME; TREATMENT RESPONSE; UPPER RESPIRATORY TRACT INFECTION; XEROSTOMIA;

ADULT; ANTIDEPRESSIVE AGENTS; CITALOPRAM; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 33847347383     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079906X167273     Document Type: Conference Paper

References (19)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington DC: American Psychiatric Association; 1994
2. Kessler RC, Berglund P, Dernier O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289:3095-105
3. World Health Organization. The World Health Report 2002: reducing risks, promoting healthy life. Geneva, Switzerland: World Health Organization; 2002
4. Hirschfeld RM, Keller MB, Panico S, et al. The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA 1997;277:333-40
5. Leon AC, Solomon DA, Mueller TI, et al. A 20-year longitudinal observational study of somatic antidepressant treatment effectiveness. Am J Psychiatry 2003;160:727-33
6. Meyers BS, Sirey JA, Bruce M, et al. Predictors of early recovery from major depression among persons admitted to community-based clinics: an observational study. Arch Gen Psychiatry 2002;59:729-35
7. Lepola UM, Loft H, Reines EH. Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care. Int Clin Psychopharmacol 2003;18:211-7
8. Burke WJ, Gergel I, Bose A. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients. J Clin Psychiatry 2002;63:331-6
9. Lexapro [package insert] St. Louis, MO: Forest Pharmaceuticals, Inc.; 2005
10. Zoloft [package insert] New York, NY: Pfizer Inc.; 2006
11. Fabre LF, Abuzzahab FS, Amin M, et al. Sertraline safety and efficacy in major depression: a double-blind fixed-dose comparison with placebo. Biol Psychiatry 1995;38:592-602
12. IMS Health Incorporated Web site. Available from http://www.imshealth. com/ims/portal/pages/homeFlash/us/0,2764,6599,00.html [Last accessed 17 July 2006]
13. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59 (Suppl 20):22-57
14. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-9
15. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62
16. Guy W. ECDEU assessment manual for psychopharmacology. US Department Health, Education, and Welfare publication (ADM) 76-338. Rockville, MD: National Institute of Mental Health; 1976 pp.218-22
17. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50-5
18. Radloff L. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385-401
19. Endicott J, Nee J, Harrison W, et al. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull 1993;29:321-6